Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wisdom stevia GRAS notice

This article was originally published in The Tan Sheet

Executive Summary

FDA has no objections to Wisdom Natural Brands' affirmation that its stevia-based SweetLeaf Sweetener is generally recognized as safe, according to a letter the firm receives Sept. 1. Wisdom founder Jim May called FDA's validation "a tremendous victory" following research to prove the extract's safety and quality. Other firms including Blue California, Cargill and McNeil Nutritionals have received "no objection" notices from FDA regarding sweeteners made with the stevia preparation rebaudioside A (1"The Tan Sheet" July 6, 2009). SweetLeaf Sweetener was on the market for more than a year before Gilbert, Ariz.-based Wisdom received FDA's response to its GRAS affirmation

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103330

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel